Absci (ABSI) Non-Current Deferred Tax Liability (2021 - 2024)

Absci's (ABSI) quarterly Non-Current Deferred Tax Liability came in at $175000.0 in Q3 2024, down 29.72% year-on-year from $249000.0 in Q4 2023, and little changed quarter-over-quarter from $175000.0 in Q2 2024.

Absci (ABSI) Non-Current Deferred Tax Liability (2021 - 2024) Analysis & Trends

Absci has disclosed Non-Current Deferred Tax Liability across 4 years of filings, most recently posting $175000.0 for Q3 2024.

  • Non-Current Deferred Tax Liability for Q3 2024 came in at $175000.0, down 29.72% year-over-year; the trailing twelve-month figure through Sep 2024 was $175000.0 (down 29.72% YoY), and the FY2023 annual result was $186000.0, down 98.96% from the prior year.
  • Non-Current Deferred Tax Liability came in at $175000.0 for Q3 2024 at Absci, roughly flat from $175000.0 in the prior quarter.
  • In the past five years, Non-Current Deferred Tax Liability ranged from a high of $17.9 million in Q4 2022 to a low of $175000.0 in Q1 2024.
  • The 4-year median for Non-Current Deferred Tax Liability is $496000.0 (2021), against an average of $2.3 million.
  • Across the five-year window, Non-Current Deferred Tax Liability jumped 2308.61% in 2022 and plunged 98.96% in 2023, its largest moves.
  • Absci's Non-Current Deferred Tax Liability stood at $743000.0 in 2021, then surged by 2308.61% to $17.9 million in 2022, then slumped by 98.96% to $186000.0 in 2023, then declined by 5.91% to $175000.0 in 2024.
  • The last three Non-Current Deferred Tax Liability figures came in at $175000.0 (Q3 2024), $175000.0 (Q2 2024), and $175000.0 (Q1 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Absci 1.13 Bn 1.01 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2024 175,000.00
Sep 30, 2024 175,000.00
Jun 30, 2024 175,000.00
Jun 30, 2024 175,000.00
Mar 31, 2024 175,000.00
Mar 31, 2024 175,000.00
Dec 31, 2023 186,000.00
Dec 31, 2023 186,000.00
Sep 30, 2023 249,000.00
Sep 30, 2023 249,000.00
Jun 30, 2023 223,000.00
Jun 30, 2023 223,000.00
Mar 31, 2023 224,000.00
Mar 31, 2023 224,000.00
Dec 31, 2022 17.90 Mn
Dec 31, 2022 17.90 Mn
Sep 30, 2022 756,000.00
Sep 30, 2022 756,000.00
Jun 30, 2022 1.09 Mn
Jun 30, 2022 1.09 Mn